User profiles for Min Jin Ha
 | MIN JIN HAGraduate School of Public Health, Yonsei University Verified email at yuhs.ac Cited by 2461 |
[HTML][HTML] Structure-based classification predicts drug response in EGFR-mutant NSCLC
Epidermal growth factor receptor (EGFR) mutations typically occur in exons 18–21 and are
established driver mutations in non-small cell lung cancer (NSCLC) 1 , 2 – 3 . Targeted …
established driver mutations in non-small cell lung cancer (NSCLC) 1 , 2 – 3 . Targeted …
Heritability and genomics of gene expression in peripheral blood
We assessed gene expression profiles in 2,752 twins, using a classic twin design to quantify
expression heritability and quantitative trait loci (eQTLs) in peripheral blood. The most …
expression heritability and quantitative trait loci (eQTLs) in peripheral blood. The most …
DINGO: differential network analysis in genomics
Motivation: Cancer progression and development are initiated by aberrations in various
molecular networks through coordinated changes across multiple genes and pathways. It is …
molecular networks through coordinated changes across multiple genes and pathways. It is …
An improved patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses
IM Meraz, M Majidi, F Meng, RP Shao, MJ Ha… - Cancer immunology …, 2019 - AACR
Human tumor xenograft models do not replicate the human immune system and tumor
microenvironment. We developed an improved humanized mouse model, derived from fresh cord …
microenvironment. We developed an improved humanized mouse model, derived from fresh cord …
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer
…, MG Durak, T Bui, M Kohansal, MJ Ha… - Clinical Cancer …, 2019 - AACR
Purpose: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors are currently used in
combination with endocrine therapy to treat advanced hormone receptor–positive, HER2-negative …
combination with endocrine therapy to treat advanced hormone receptor–positive, HER2-negative …
Cytoplasmic cyclin E predicts recurrence in patients with breast cancer
Purpose: Low molecular weight cyclin E (LMW-E) detected by Western blot analysis predicts
for reduced breast cancer survival; however, it is impractical for clinical use. LMW-E lacks a …
for reduced breast cancer survival; however, it is impractical for clinical use. LMW-E lacks a …
[HTML][HTML] Intravenous immunoglobulin G suppresses heat shock protein (HSP)-70 expression and enhances the activity of HSP90 and proteasome inhibitors
Intravenous immunoglobulin G (IVIgG) is approved for primary immunodeficiency
syndromes but may induce anti-cancer effects, and while this has been attributed to its anti-…
syndromes but may induce anti-cancer effects, and while this has been attributed to its anti-…
pH-responsive assembly of gold nanoparticles and “spatiotemporally concerted” drug release for synergistic cancer therapy
A challenge in using plasmonic nanostructure–drug conjugates for thermo–chemo
combination cancer therapy lies in the huge size discrepancy; the size difference can critically …
combination cancer therapy lies in the huge size discrepancy; the size difference can critically …
A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells
…, Q Gao, BW Shi, HH Pan, YT Huang, M Jin… - Journal of molecular …, 2012 - Springer
The objective of this study was to explore whether hyperandrogenism induces epigenetic
alterations of peroxisome proliferator-activated receptor gamma 1 (PPARG1), nuclear …
alterations of peroxisome proliferator-activated receptor gamma 1 (PPARG1), nuclear …
Polysaccharide-based biomaterials in tissue engineering: a review
… In addition to the commercially available products of injectable HA, HA-based scaffolds
have also been studied. For example, HA serves as a suitable bioink with other synthetic …
have also been studied. For example, HA serves as a suitable bioink with other synthetic …